Leadership

Our team brings together pioneers in NK cells and leaders in cell therapy product development.


Founded by pioneers in NK cell engineering and biology and steered by a leadership team with deep cell therapy experience, Catamaran has assembled the collective expertise to develop transformative cell therapies to treat cancer.

We have a purpose-built team of scientists and drug developers who have the specific know-how and proven track records needed to design, develop and manufacture novel CAR-NK cell therapies. We have come together at Catamaran to discover and develop CAR-NK cell therapies that will change the lives of cancer patients.

Our scientific founders, Branden Moriarity, PhD of the University of Minnesota and Catherine Bollard, MD of the George Washington University Cancer Center, are pioneers in NK cell biology, engineering, manufacturing and clinical application. Both of our founders are proven innovators in cell therapy and bring complementary expertise, with Dr. Moriarity’s discoveries in non-viral cell engineering and Dr. Bollard’s discoveries related to potency-boosting switches for NK cells.

The Catamaran leadership team has deep expertise building cell therapy platforms and rapidly advancing product pipelines. Each member of our team has worked in the emerging cell therapy field with first-hand experience discovering and developing cell therapy products. From NK cell biology and synthetic biology through translation to the clinic and product manufacturing, we bring our unique insights and passion to develop improved cell therapies for patients.

Alvin Shih, MD, MBA

Alvin Shih, MD, MBA

CEO

Cherry Thomas, MD

Cherry Thomas, MD

Chief Medical Officer

Scott Holmes, MS, MBA

Scott Holmes, MS, MBA

Chief Financial Officer

Vipin Suri, PhD, MBA

Vipin Suri, PhD, MBA

Chief Scientific Officer

Dave Sutherland

Dave Sutherland

Vice President, Finance

Dominic Picarella, PhD

Dominic Picarella, PhD

Senior Director, In Vivo Pharmacology

Finola Moore, PhD

Finola Moore, PhD

Director, Pipeline Research

Joseph Gold, PhD

Joseph Gold, PhD

Vice President, Technical Operations and Manufacturing

Lilian Yengi, PhD

Lilian Yengi, PhD

Vice President, Preclinical Development and Biomarkers

Mike DeRidder, PhD

Mike DeRidder, PhD

Senior Vice President, Corporate Strategy and New Product Planning

Tara Place, MBA

Tara Place, MBA

Vice President, Human Resources and Organizational Effectiveness

Scientific Founders


Branden Moriarity, PhD

Branden Moriarity, PhD

Scientific Founder

Catherine Bollard, MD

Catherine Bollard, MD

Scientific Founder